The nation of Zimbabwe has rejected a substantial US healthcare agreement valued at $367m (272 million pounds) over five years because of Washington's request for confidential biological samples.
The decision became public following a internal memorandum dated December was leaked, which showed President Emmerson Mnangagwa believed the agreement was "skewed".
A government spokesperson later explained that the US was seeking biological samples for research and profit while refused to guarantee the resulting advantages from any future treatments.
"We will now turn to the challenging and unfortunate task of scaling back our health assistance in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont in a statement.
The US Embassy indicated the US had furnished more than $1.9bn in health funding to Zimbabwe over the last two decades.
A physicians' group in Zimbabwe has called for more talks to reach a deal acceptable to both sides so the nation's critical HIV treatment initiative can continue.
Broader Background
This rejection comes after a comparable situation in Kenya, where a court blocked a related health funding agreement following legal challenges were raised about the security of Kenyans' medical information.
Since returning to office last year, US President Donald Trump has slashed overseas assistance and closed the US Agency for International Development (USAID).
The agency had managed assistance for the American government, but Trump claimed its spending was "inefficient" and his government was seeking government-to-government agreements to enhance openness and accountability.
As per reports, 16 African countries have so far agreed to these new agreements, representing over $18.3bn of fresh investment.
Specifics of the Rejected Agreement
The funds for Zimbabwe was intended to gone towards "tackling HIV/Aids, TB, malaria, maternal and child health, and disease outbreak preparedness.
"We are confident this cooperation could have provided immense advantages for Zimbabwean communities, particularly the 1.2 million men, women and children currently on HIV treatment via US-supported initiatives," the Ambassador said.
However, government spokesperson Nick Mangwana argued the proposed deal was "asymmetrical".
"The proposal required Zimbabwe to surrender its biological resources and data for a long time, with no corresponding assurance of benefiting from any scientific breakthroughs – such as new medicines or tests – that could result from that shared data," he stated.
"Effectively, our nation would provide the raw materials for medical research without any assurance that the end products would be accessible to our citizens if a new health crisis arise."
National Interest and Global Health
He also noted that the American exit from the World Health Organization (WHO) and its push of one-on-one deals were undermining frameworks already established through the international organization.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing framework created to deal with future global health emergencies.
"This system is designed to ensure that when a nation provides its samples, the resulting advantages – such as vaccines and treatments – are distributed fairly, not commercialised solely by those with the capability to develop them."
The government's concerns regarding the US deal "are not meant as hostility towards the US," Mangwana stressed.
"We welcome ongoing discussions with our American counterparts on how subsequent co-operation might be structured in a way that honours the sovereignty and interests of each country."
Medical Community Reaction
A leading public health body expressed it understood the government's concerns, but urged that talks need to persist considering much of the country's Aids initiatives were funded by external financing.
"If technical issues exist, including those involving information security or agreement terms, these can frequently be addressed through detailed discussion and negotiated safeguards," it commented.
The halted deal highlights the ongoing debate between receiving much-needed international aid and protecting national sovereignty in an ever more interconnected world.